Literature DB >> 31448498

Intrathecal Gadolinium Use for the Chronic Pain Physician.

Jonathan M Hagedorn1, Markus A Bendel1, Susan M Moeschler1, Tim J Lamer1, Jason E Pope2, Timothy R Deer3.   

Abstract

INTRODUCTION: The approach to intrathecal (IT) drug delivery malfunction is complicated, particularly for iodine-allergic patients. In these situations, the current literature has not addressed the use of IT gadolinium. Case reports exist showing severe neurotoxic manifestations with IT gadolinium use. We sought to provide a resource for chronic pain physicians treating an iodine-allergic patient and considering the use of IT gadolinium.
METHODS: A thorough literature search identified 11 published cases of gadolinium-induced neurotoxicity due to IT injection and those cases are described in detail. The literature was also reviewed for safe dosages of IT gadolinium.
RESULTS: After thorough review, a safe IT gadolinium dose is provided. Additionally, an algorithm was developed for the workup of an IT pump malfunction in iodine allergic patients.
CONCLUSION: Herein, we provide guidance on IT gadolinium usage and a framework for IT pump malfunction in iodine allergic patients.
© 2019 International Neuromodulation Society.

Entities:  

Keywords:  Chronic pain; gadolinium; intrathecal drug delivery; programmable pump; safety

Mesh:

Substances:

Year:  2019        PMID: 31448498     DOI: 10.1111/ner.13043

Source DB:  PubMed          Journal:  Neuromodulation        ISSN: 1094-7159


  1 in total

1.  Intrathecal 99mTc-DTPA imaging of molecular passage from lumbar cerebrospinal fluid to brain and periphery in humans.

Authors:  Ajay Verma; Jacob Y Hesterman; J Levi Chazen; Robert Holt; Patrick Connolly; Laura Horky; Shankar Vallabhajosula; P David Mozley
Journal:  Alzheimers Dement (Amst)       Date:  2020-04-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.